|
ZSCAN12P1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.754310E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.361800E-04 |
| Normal-vs-Stage2 |
2.246300E-04 |
| Normal-vs-Stage3 |
2.07689999999205E-05 |
| Normal-vs-Stage4 |
3.404500E-04 |
| Stage1-vs-Stage2 |
4.769200E-01 |
| Stage1-vs-Stage3 |
9.597000E-03 |
| Stage1-vs-Stage4 |
6.517000E-01 |
| Stage2-vs-Stage3 |
1.261000E-01 |
| Stage2-vs-Stage4 |
9.419200E-01 |
| Stage3-vs-Stage4 |
1.591780E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.622160E-04 |
| Normal-vs-AfricanAmerican |
1.803330E-04 |
| Normal-vs-Asian |
2.396800E-04 |
| Caucasian-vs-AfricanAmerican |
6.037000E-01 |
| Caucasian-vs-Asian |
9.135000E-01 |
| AfricanAmerican-vs-Asian |
6.309400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.048800E-04 |
| Normal-vs-Female |
1.410360E-04 |
| Male-vs-Female |
4.499000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.042040E-03 |
| Normal-vs-Age(41-60Yrs) |
8.13210000000231E-05 |
| Normal-vs-Age(61-80Yrs) |
5.65849999999424E-05 |
| Normal-vs-Age(81-100Yrs) |
2.423000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.563700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.953670E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.114200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.864800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.685400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.297800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.31339999986935E-07 |
| Classical-VS-Follicular |
5.819200E-01 |
| Classical-VS-Other |
4.002600E-01 |
| Classical-VS-Normal |
2.555800E-04 |
| Tall-VS-Follicular |
9.566100E-04 |
| Tall-VS-Other |
6.977700E-02 |
| Tall-VS-Normal |
1.04389999999732E-06 |
| Follicular-VS-Other |
6.763800E-01 |
| Follicular-VS-Normal |
1.217780E-03 |
| Other-VS-Normal |
5.153800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.380390E-04 |
| Normal-vs-N1 |
5.97729999999297E-05 |
| N0-vs-N1 |
4.031200E-01 |
|
|
